Vital KSK Holdings (3151) Stock Overview
Engages in the wholesale and retail sale of pharmaceutical products in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
3151 Community Fair Values
See what others think this stock is worth. Follow their fair value or set your own to get alerts.
Vital KSK Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,287.00 |
| 52 Week High | JP¥1,396.00 |
| 52 Week Low | JP¥1,093.00 |
| Beta | 0.18 |
| 1 Month Change | 4.04% |
| 3 Month Change | -0.46% |
| 1 Year Change | 7.61% |
| 3 Year Change | 55.06% |
| 5 Year Change | 48.79% |
| Change since IPO | 130.65% |
Recent News & Updates
Vital KSK Holdings (TSE:3151) Has Announced A Dividend Of ¥34.00
Dec 04Vital KSK Holdings' (TSE:3151) Solid Profits Have Weak Fundamentals
Nov 21Recent updates
Shareholder Returns
| 3151 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | -1.0% | 0.2% | 1.2% |
| 1Y | 7.6% | 10.9% | 22.7% |
Return vs Industry: 3151 underperformed the JP Healthcare industry which returned 10.9% over the past year.
Return vs Market: 3151 underperformed the JP Market which returned 22.7% over the past year.
Price Volatility
| 3151 volatility | |
|---|---|
| 3151 Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 3151 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3151's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 3,756 | Taisuke Murai | www.vitalksk.co.jp |
Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company sells poisonous or deleterious substances, narcotics, quasi-drugs, medical equipment and devices, sanitary materials, hygiene goods, nursing care products, and beverages; and test reagents, agricultural chemicals, epidemiological agents and materials, industrial chemicals, veterinary drugs, poisonous and deleterious substances, paints, pigments, dyes, regenerative medicine products, and other chemicals, as well as well as chemicals for scientific use. It is also involved in the operation pharmacies; provision of medical management consulting services for medical institutions such as hospitals, nursing care providers, and local governments; wholesale of agricultural chemicals and agricultural materials; nursing care-related business; rental and sales of welfare equipment and home modification; general freight vehicle transportation activities; and insurance agency, real estate management, and parking lot operation businesses
Vital KSK Holdings, Inc. Fundamentals Summary
| 3151 fundamental statistics | |
|---|---|
| Market cap | JP¥62.99b |
| Earnings (TTM) | JP¥9.86b |
| Revenue (TTM) | JP¥603.53b |
Is 3151 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3151 income statement (TTM) | |
|---|---|
| Revenue | JP¥603.53b |
| Cost of Revenue | JP¥554.30b |
| Gross Profit | JP¥49.23b |
| Other Expenses | JP¥39.37b |
| Earnings | JP¥9.86b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 203.73 |
| Gross Margin | 8.16% |
| Net Profit Margin | 1.63% |
| Debt/Equity Ratio | 5.7% |
How did 3151 perform over the long term?
See historical performance and comparisonDividends
Does 3151 pay a reliable dividends?
See 3151 dividend history and benchmarks| Vital KSK Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Mar 30 2026 |
| Dividend Pay Date | Jun 05 2026 |
| Days until Ex dividend | 110 days |
| Days until Dividend pay date | 177 days |
Does 3151 pay a reliable dividends?
See 3151 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/09 11:58 |
| End of Day Share Price | 2025/12/09 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vital KSK Holdings, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
